IL-1β induces gastric cancer by blocking the production of gastric acid, causing epigenetic changes, stimulating angiogenesis, attracting adhesive factors, and releasing other inflammatory factors, such as interleukin-8 (IL-8/CXCL8) (8–11). Here, CXCL8 is linked to gastric cancer.